Published in Infect Immun on June 01, 1992
Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells. J Virol (2002) 1.28
Adjuvants for human vaccines. Curr Opin Immunol (2012) 1.25
Dermal inflammation elicited by synthetic analogs of Treponema pallidum and Borrelia burgdorferi lipoproteins. Infect Immun (1995) 1.06
Role of lipid structure in the humoral immune response in mice to covalent lipid-peptides from the membrane proximal region of HIV-1 gp41. Vaccine (2009) 1.00
Liposomes containing lipid A serve as an adjuvant for induction of antibody and cytotoxic T-cell responses against RTS,S malaria antigen. Infect Immun (1998) 0.98
Enhancing nicotine vaccine immunogenicity with liposomes. Bioorg Med Chem Lett (2012) 0.91
The Neisseria meningitidis macrophage infectivity potentiator protein induces cross-strain serum bactericidal activity and is a potential serogroup B vaccine candidate. Infect Immun (2011) 0.87
Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen. Infect Immun (2000) 0.87
Immunization with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci. Infect Immun (2001) 0.86
Pathways for potentiation of immunogenicity during adjuvant-assisted immunizations with Plasmodium falciparum major merozoite surface protein 1. Infect Immun (1998) 0.84
A review of the development of a vehicle for localized and controlled drug delivery for implantable biosensors. J Diabetes Sci Technol (2008) 0.84
Highly effective generic adjuvant systems for orphan or poverty-related vaccines. Vaccine (2010) 0.83
The Use of Synthetic Carriers in Malaria Vaccine Design. Vaccines (Basel) (2015) 0.80
Intracellular processing of liposome-encapsulated antigens by macrophages depends upon the antigen. Infect Immun (1995) 0.79
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem (1982) 27.26
SIMPLIFIED MYELOPEROXIDASE STAIN USING BENZIDINE DIHYDROCHLORIDE. Blood (1965) 9.42
Comparative testing of monoclonal antibodies against Plasmodium falciparum sporozoites for ELISA development. Bull World Health Organ (1987) 4.65
Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha. J Immunol (1990) 3.79
Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection. J Immunol (1988) 2.82
Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells. Cell (1991) 1.81
Cellular requirements for lipopolysaccharide adjuvanticity. A role for both T lymphocytes and macrophages for in vitro responses to particulate antigens. J Exp Med (1979) 1.73
Immunological adjuvants: a role for liposomes. Immunol Today (1990) 1.52
Liposomes as carriers of antigens and adjuvants. J Immunol Methods (1991) 1.36
Use of adjuvant containing mycobacterial cell-wall skeleton, monophosphoryl lipid A, and squalane in malaria circumsporozoite protein vaccine. Lancet (1991) 1.20
Modulation of the biological activity of bacterial endotoxin by incorporation into liposomes. J Immunol (1987) 1.11
Liposomes, lipid A, and aluminum hydroxide enhance the immune response to a synthetic malaria sporozoite antigen. Infect Immun (1988) 1.03
Participation of hyaluronic acid in the macrophage disappearance reaction. Immunol Commun (1980) 1.02
Effect of liposome encapsulation on antigen presentation in vitro. Comparison of presentation by peritoneal macrophages and B cell tumors. J Immunol (1989) 1.00
Liposomes containing lipid A: a potent nontoxic adjuvant for a human malaria sporozoite vaccine. Immunol Lett (1990) 0.97
Interactions of lipid a and liposome-associated lipid A with Limulus polyphemus amoebocytes. Infect Immun (1983) 0.94
Enhancement of liposomal model membrane immunogenicity by incorporation of lipid A. J Immunol (1977) 0.94
Plasmodium falciparum: sporozoite boosting of immunity due to a T-cell epitope on a sporozoite vaccine. Exp Parasitol (1987) 0.91
Phagocytosis of liposomes by macrophages: intracellular fate of liposomal malaria antigen. Biochim Biophys Acta (1991) 0.90
Incorporation of LPS in liposomes diminishes its ability to induce tumoricidal activity and tumor necrosis factor secretion in murine macrophages. J Leukoc Biol (1988) 0.88
The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators. J Reticuloendothel Soc (1983) 0.88
Mitogenic activities of lipid A and liposome-associated lipid A: effects of epitope density. Rev Infect Dis (1984) 0.87
Immunogenicity of liposomal malaria sporozoite antigen in monkeys: adjuvant effects of aluminium hydroxide and non-pyrogenic liposomal lipid A. Vaccine (1989) 0.87
Antitumoral properties and reduced toxicity of LPS targeted to macrophages via normal or mannosylated liposomes. Anticancer Res (1990) 0.83
Complement-dependent phagocytosis of liposomes by macrophages. Methods Enzymol (1987) 0.79
Ecological meltdown in predator-free forest fragments. Science (2001) 9.84
A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group. N Engl J Med (1997) 8.22
Unintended changes in cognition, mood, and behavior arising from cell-based interventions for neurological conditions: ethical challenges. Am J Bioeth (2009) 6.13
Typhoid fever in children aged less than 5 years. Lancet (1999) 6.00
Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science (1994) 4.50
Field trials of the Baby Check score card: mothers scoring their babies at home. Arch Dis Child (1991) 4.31
Activation of macrophages for destruction of Francisella tularensis: identification of cytokines, effector cells, and effector molecules. Infect Immun (1992) 3.09
The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med (1994) 2.92
Multipractice analysis of laparoscopic cholecystectomy in 1,983 patients. Am J Surg (1992) 2.87
Loss-of-function mutations in a human gene related to Chlamydomonas reinhardtii dynein IC78 result in primary ciliary dyskinesia. Am J Hum Genet (1999) 2.77
Molecular and biotechnological aspects of xylanases. FEMS Microbiol Rev (1999) 2.76
Field trials of the Baby Check score card in hospital. Arch Dis Child (1991) 2.64
The choice of T-cell epitopes utilized on a protein antigen depends on multiple factors distant from, as well as at the determinant site. Immunol Rev (1987) 2.56
Diversity of sulfate-reducing bacteria in oxic and anoxic regions of a microbial mat characterized by comparative analysis of dissimilatory sulfite reductase genes. Appl Environ Microbiol (1999) 2.55
Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria. J Infect Dis (2001) 2.54
Control of oligodendrocyte differentiation by the Nkx2.2 homeodomain transcription factor. Development (2001) 2.43
Field trials of the Baby Check score card in general practice. Arch Dis Child (1991) 2.39
Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage. Hepatology (2000) 2.10
Mutations in NALP12 cause hereditary periodic fever syndromes. Proc Natl Acad Sci U S A (2008) 2.06
Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine. J Infect Dis (1998) 2.00
Transcutaneous immunization: a human vaccine delivery strategy using a patch. Nat Med (2000) 1.98
Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate. Oncogene (2010) 1.87
Interaction of Sindbis virus with liposomal model membranes. J Virol (1975) 1.85
Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: involvement of interferon gamma and CD8+ T cells. J Exp Med (1994) 1.83
Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine. J Infect Dis (1995) 1.83
Antibody response to accelerated immunisation with diphtheria, tetanus, pertussis vaccine. Lancet (1993) 1.82
Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs. Proc Natl Acad Sci U S A (1978) 1.82
Persistently negative tuberculin reactions: their presence among children with culture positive for Mycobacterium tuberculosis (tuberculin-negative tuberculosis). Am J Dis Child (1980) 1.78
Complement-dependent damage to liposomes prepared from pure lipids and Forssman hapten. Biochemistry (1969) 1.75
Unexpected population distribution in a microbial mat community: sulfate-reducing bacteria localized to the highly oxic chemocline in contrast to a eukaryotic preference for anoxia. Appl Environ Microbiol (1999) 1.75
Life and death of an intracellular pathogen: Francisella tularensis and the macrophage. Immunol Ser (1994) 1.73
IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism. J Immunol (1991) 1.73
Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1. J Immunol (1991) 1.71
Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer. N Engl J Med (1981) 1.70
Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. J Infect Dis (1998) 1.66
First place--resident clinical science award 1999. Quality of life for children with obstructive sleep apnea. Otolaryngol Head Neck Surg (2000) 1.65
Passive immunotherapy in the treatment of advanced human immunodeficiency virus infection. J Infect Dis (1993) 1.63
Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions. Ann Oncol (2003) 1.63
The cellular function of MASH1 in autonomic neurogenesis. Neuron (1995) 1.62
Cardiac involvement in Wilson's disease--an electrocardiographic observation. J Assoc Physicians India (2004) 1.58
A 20-year experience of electron microscopy in the diagnosis of primary ciliary dyskinesia. Eur Respir J (2009) 1.58
Cell-based interventions for neurologic conditions: ethical challenges for early human trials. Neurology (2008) 1.57
RPGR is mutated in patients with a complex X linked phenotype combining primary ciliary dyskinesia and retinitis pigmentosa. J Med Genet (2005) 1.56
Incidence of hepatotoxicity in children receiving isoniazid chemoprophylaxis. Pediatr Infect Dis J (1989) 1.56
Skin immunization made possible by cholera toxin. Nature (1998) 1.55
The role of tumor necrosis factor-alpha in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride. Toxicol Appl Pharmacol (2001) 1.51
A 5' splice-region G----C mutation in exon 1 of the human beta-globin gene inhibits pre-mRNA splicing: a mechanism for beta+-thalassemia. Proc Natl Acad Sci U S A (1989) 1.48
Molecular docking programs successfully predict the binding of a beta-lactamase inhibitory protein to TEM-1 beta-lactamase. Nat Struct Biol (1996) 1.48
Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants. Infect Immun (2000) 1.48
Recognition of E-cadherin on epithelial cells by the mucosal T cell integrin alpha M290 beta 7 (alpha E beta 7). Eur J Immunol (1995) 1.47
Experience with flexible fiberoptic bronchoscopy with bronchoalveolar lavage as a diagnostic tool in children with AIDS. Am J Dis Child (1992) 1.47
MEFV-Gene analysis in armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet (1999) 1.44
Prevalence, risk factors and awareness of hypertension in India: a systematic review. J Hum Hypertens (2012) 1.43
Policies for study monitoring and interim reporting of results. J Clin Oncol (1987) 1.41
Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge. J Immunol (1998) 1.41
Evaluation of efficacy and safety of losartan potassium in the treatment of mild to moderate hypertension as compared to enalapril maleate. J Assoc Physicians India (2000) 1.40
Vancomycin resistant enterococci in New Zealand. N Z Med J (1999) 1.38
Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy. Proc Natl Acad Sci U S A (1992) 1.37
Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nat Genet (2000) 1.37
Early initiation of breastfeeding and the risk of infant diarrhea in rural Egypt. Pediatrics (1999) 1.37
DT-MRI denoising and neuronal fiber tracking. Med Image Anal (2004) 1.35
Cell lineage determination and the control of neuronal identity in the neural crest. Cold Spring Harb Symp Quant Biol (1997) 1.35
Phenotypic diversity of enterotoxigenic Escherichia coli strains from a community-based study of pediatric diarrhea in periurban Egypt. J Clin Microbiol (1999) 1.35
A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous, cell-free simian immunodeficiency virus challenge. J Virol (1995) 1.33
Chemical modification of xylanases: evidence for essential tryptophan and cysteine residues at the active site. Biochim Biophys Acta (1990) 1.32
Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants. Infect Immun (1999) 1.32
Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study. J Natl Cancer Inst (1998) 1.32
Characterization of a monoclonal antibody directed against the murine B lymphocyte receptor for IgE. J Immunol (1987) 1.31
Production of antibodies against phosphocholine, phosphatidylcholine, sphingomyelin, and lipid A by injection of liposomes containing lipid A. J Immunol (1979) 1.30
The significance of anti-S sensitization in pregnancy. Clin Lab Haematol (1990) 1.30
Effect of B cell stimulatory factor-1 (interleukin 4) on Fc epsilon and Fc gamma receptor expression on murine B lymphocytes and B cell lines. J Immunol (1987) 1.29
Genetic linkage of recessive dystrophic epidermolysis bullosa to the type VII collagen gene. J Clin Invest (1992) 1.29
MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei. J Immunol (1996) 1.29
Sieve analysis: methods for assessing from vaccine trial data how vaccine efficacy varies with genotypic and phenotypic pathogen variation. J Clin Epidemiol (2001) 1.29
Breast-feeding and the risk of life-threatening rotavirus diarrhea: prevention or postponement? Pediatrics (1993) 1.28
2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate. Cancer Metastasis Rev (2000) 1.28
Mutations in the catalytic domain of human coagulation factor IX: rapid characterization by direct genomic sequencing of DNA fragments displaying an altered melting behavior. Genomics (1989) 1.26
Mutations in the autoinflammatory cryopyrin-associated periodic syndrome gene: epidemiological study and lessons from eight years of genetic analysis in France. Ann Rheum Dis (2010) 1.26
Safety and immunogenicity of an oral, killed enterotoxigenic Escherichia coli-cholera toxin B subunit vaccine in Egyptian adults. J Infect Dis (1998) 1.26
Cytotoxic T lymphocytes to Ebola Zaire virus are induced in mice by immunization with liposomes containing lipid A. Vaccine (1999) 1.25
Antibodies to cholesterol. Proc Natl Acad Sci U S A (1988) 1.25
The hyaluronate receptor is identical to a glycoprotein of Mr 85,000 (gp85) as shown by a monoclonal antibody that interferes with binding activity. J Biol Chem (1987) 1.24
Species-specific alternative splice mimicry at the growth hormone receptor locus revealed by the lineage of retroelements during primate evolution. J Biol Chem (2000) 1.23
HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160. J Immunol (1998) 1.22
A new & robust information theoretic measure and its application to image alignment. Inf Process Med Imaging (2003) 1.22
Reactivities of serotyping monoclonal antibodies with culture-adapted human rotaviruses. J Clin Microbiol (1991) 1.22
Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys. Antimicrob Agents Chemother (1986) 1.22
Epidemiology of enterotoxigenic Escherichia coli diarrhea in a pediatric cohort in a periurban area of lower Egypt. J Infect Dis (1999) 1.21
Delivery of liposome-encapsulated drugs to macrophages. Pharmacol Ther (1983) 1.20
Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group. J Infect Dis (1999) 1.20
Use of adjuvant containing mycobacterial cell-wall skeleton, monophosphoryl lipid A, and squalane in malaria circumsporozoite protein vaccine. Lancet (1991) 1.20
Improved therapy of experimental leishmaniasis by use of a liposome-encapsulated antimonial drug. Life Sci (1978) 1.19
Impact of infection by Helicobacter pylori on the risk and severity of endemic cholera. J Infect Dis (1995) 1.19
Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4. Am J Hum Genet (2001) 1.18
Evaluating new vaccines for developing countries. Efficacy or effectiveness? JAMA (1996) 1.18
Clinical versus genetic diagnosis of familial Mediterranean fever. QJM (2000) 1.17